Case report: anti-glomerular basement membrane antibody disease with normal renal function

BMC Nephrol. 2015 Nov 4:16:185. doi: 10.1186/s12882-015-0179-1.

Abstract

Background: Anti-glomerular basement membrane (GBM) antibody disease is a rare autoimmune disorder characterized by rapidly progressive glomerulonephritis caused by autoantibodies against the α3-chain of type IV collagen in the GBM.

Case presentation: An 8-year-old girl with hematuria and proteinuria due to anti-GBM nephritis was diagnosed with hematuria and proteinuria during a school urine screening program. Her blood pressure and serum creatinine levels were normal. Her hematuria and proteinuria persisted for several months. Since a spot urine protein to creatinine ratio was around 7 g/g Cre, a percutaneous renal biopsy was performed. Immunofluorescent staining demonstrated a linear pattern for immunoglobulin G along the entire GBM. Chest computed tomography was normal. Anti-GBM antibody assays were reported as slightly raised; thus, the diagnosis was anti-GBM disease with normal renal function. Treatment included plasma exchange, intravenous high-dose methylprednisolone, and cyclophosphamide as a mainstay medication. The treatment was rapidly effective with an immediate decrease in anti-GBM titers and proteinuria.

Conclusions: Cases of anti-GBM disease with normal renal function in children are rare. Treatment in children has not been established; therefore, clinicians need to carefully select an effective treatment because the prognosis is poor.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Child
  • Cyclophosphamide / administration & dosage*
  • Diagnosis, Differential
  • Female
  • Glomerulonephritis / diagnosis*
  • Glomerulonephritis / immunology
  • Glomerulonephritis / therapy*
  • Hemorrhage / diagnosis*
  • Hemorrhage / immunology
  • Hemorrhage / therapy*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Injections, Intravenous
  • Lung Diseases / diagnosis*
  • Lung Diseases / immunology
  • Lung Diseases / therapy*
  • Methylprednisolone / administration & dosage*
  • Plasma Exchange*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Methylprednisolone

Supplementary concepts

  • Rapidly progressive glomerulonephritis with pulmonary hemorrhage